Canada markets closed
  • S&P/TSX

    20,287.80
    -24.00 (-0.12%)
     
  • S&P 500

    4,403.55
    +8.29 (+0.19%)
     
  • DOW

    34,980.97
    +45.50 (+0.13%)
     
  • CAD/USD

    0.8001
    -0.0018 (-0.22%)
     
  • CRUDE OIL

    71.12
    -2.83 (-3.83%)
     
  • BTC-CAD

    49,713.25
    -2,174.23 (-4.19%)
     
  • CMC Crypto 200

    971.46
    +10.57 (+1.10%)
     
  • GOLD FUTURES

    1,817.00
    -0.20 (-0.01%)
     
  • RUSSELL 2000

    2,232.53
    +6.29 (+0.28%)
     
  • 10-Yr Bond

    1.1660
    -0.0730 (-5.89%)
     
  • NASDAQ

    14,742.75
    +70.07 (+0.48%)
     
  • VOLATILITY

    18.72
    +0.48 (+2.63%)
     
  • FTSE

    7,081.72
    +49.42 (+0.70%)
     
  • NIKKEI 225

    27,781.02
    +497.43 (+1.82%)
     
  • CAD/EUR

    0.6735
    -0.0017 (-0.25%)
     

FSD Pharma Inc., Worldwide License of Natural Fatty Acid, CEO Clip Video

·1 min read

Vancouver, British Columbia--(Newsfile Corp. - March 6, 2020) - FSD Pharma Inc. (CSE: HUGE) (NASDAQ: HUGE) CEO and Executive Co-Chairman, Dr. Raza Bokhari speaks about the company's worldwide license of a naturally occurring fatty acid.



If you cannot view the video above, please visit:
https://www.b-tv.com/fsd-pharma-natural-fatty-acid-ceo-clips-90sec/

FSD Pharma is being featured on BNN Bloomberg on March 7th - March 8th, 2020, throughout the day and evenings.

FSD Pharma Inc. (CSE: HUGE) (NASDAQ: HUGE)

fsdpharma.com

About CEO Clips:

CEO Clips is the largest library of publicly traded company CEO videos in Canada and the US. These 90 second video profiles broadcast on national TV and online via 15 top financial sites including: Thomson Reuters, Bloomberg, Yahoo! Finance and Stockhouse.com.

BTV - Business Television/CEO Clips Contact: Trina Schlingmann (604) 664-7401 x 5 trina@b-tv.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/53226

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting